GSK-3β/β-catenin is considered to be an important downstream cascade of AKT in regulating cancer metastasis; thus, we investigated if ZSD inhibited growth and metastasis in lung cancer by modulating AKT/GSK-3β/β-catenin signaling. Here, GSK3B is linked to lung carcinoma.